Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1

Manfred Schmitt, Nadia Harbeck, Nils Brünner, Fritz Jänicke, Christoph Meisner, Bernd Mühlenweg, Heike Jansen, Julia Dorn, Ulrike Nitz, Eva J Kantelhardt, Christoph Thomssen

    72 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1'. Together they form a unique fingerprint.

    Medicine & Life Sciences